Fractional Flow Reserve Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28

1
Global Fractional Flow Reserve Market Research
and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Fractional Flow Reserve Market Research
Report The latest report by IMARC, titled
Fractional Flow Reserve Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028 " the global fractional flow
reserve market is expected to exhibit a CAGR of
11.9 during 2023-2028. Fractional flow reserve
(FFR) refers to an invasive guide wire-based
procedure that is employed to measure the blood
pressure and flow through a specific part of the
coronary artery. It is utilized in coronary
catheterization to calculate the pressure
differences across coronary artery stenosis. Its
usage aids in determining the possibility of the
stenosis impeding the delivery of oxygen to the
heart by analyzing the ratio between the maximum
achievable blood flow in a diseased coronary
artery and the theoretical maximum flow in a
normal coronary artery. It is essential for
assessing if the patient requires angioplasty or
stenting on intermediate blockages. It is widely
recommended by healthcare professionals as this
procedure assists in avoiding unnecessary
surgeries, such as a stent or bypass surgery,
while saving costs. Request Free Sample Report
https//www.imarcgroup.com/fractional-flow-reserve
-market/requestsample
4
Report Description and Highlights
Report Description

Global Fractional Flow Reserve Market
Trends The market is primarily driven by the
increasing incidences of cardiovascular diseases
(CVDs), such as coronary artery diseases and high
blood pressure, across the globe. FFR is
extensively recommended by healthcare
professionals for assessing the possibility of
stenosis that can be responsible for inducible
ischemia. This, in turn, is creating a positive
outlook for the market. There has also been a
significant rise in the occurrence of several
chronic diseases, including type II diabetes.
This can be accredited to the sedentary lifestyle
patterns and increasing consumption of fast food
among the masses. Since type II diabetes can
often lead to the development of fatty cells in
the coronary artery of the patients and result in
blockages, further causing a stroke or a heart
attack, this is, therefore, expected to catalyze
the demand for FFR on the global level. The
market is further driven by the rising geriatric
population as the elderly are more prone to
developing CVDs and diabetes. Moreover, the
increasing number of favorable clinical outcomes
for percutaneous coronary intervention (PCI)
guided by FFR are creating a positive outlook for
the market. This, along with rising investments
in research and development (RD) activities, is
contributing to the market growth
further. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Product FFR
Guidewires FFR Monitoring Systems Brea
kup by Application Multi-Vessel Coronar
y Artery Disease Single-Vessel Coronary
Artery Disease Breakup by End User Hos
pitals and Ambulatory Surgery Centers
Diagnostic Centers Others Bre
akup by Region North America
United States Canada
Asia Pacific

6
Report Description and Highlights
Report Description
China Japan
India South Kore
a Australia In
donesia Others Europe
Germany France
United Kingdom
Italy Spain
Russia Others Latin Am
erica Brazil M
exico Others Middle Ea
st and Africa

7
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Abbott Laboratories ACIST Medical Systems Inc. (Br
  acco S.p.A.) Boston Scientific Corporation CathWor
  ks Inc. Heartflow Inc. Koninklijke Philips N.V. Op
  sens Solutions Pie Medical Imaging B.V. (Esaote Gr
  oup)
• Siemens Healthcare Private Limited (Siemens AG)
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/fractional-flow-reserve
  -market

8
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
11

Contact Us